Search Results - subject_exact:"Pharmaceuticals"

Firm-level innovation and the role of political capabilities : evidence for the pharmaceuticals industry

Saha, Amrita; Pozo Segura, Juan Manuel del; Palazzo, Gabriel - 2025

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015405762

What economists should know about the 340B Drug Discounting Program

Courtemanche, Charles; Garuccio, Joseph - 2025

The 340B Drug Pricing Program was instituted to bolster the health care safety net without relying on taxpayer money. It allows participating health care facilities - most of which are hospitals - to purchase drugs filled at in-house or contracted external pharmacies at discounts from...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015395374

Show one more version 1

What Economists Should Know about the 340B Drug Discounting Program

Courtemanche, Charles; Garuccio, Joseph - 2025

Book / Working Paper

Greening the pharmaceutical supply chain

Belal, Md Mostain; Shukla, Vinaya; Sreejith Balasubramanian - 2025

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015357789

Free entry and social inefficiency in regulated pharmacy markets

Jokelainen, Antto; Markkanen, Jaakko; Leppälä, Samuli; … - 2025

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015407341

Show one more version 1

Free entry and social inefficiency in regulated pharmacy markets

Jokelainen, Antto; Markkanen, Jaakko; Leppälä, Samuli; … - 2025 - [Updated] April 2025

Edition: [Updated] April 2025

Book / Working Paper

Bargaining power and quantity discounts to retailers : evidence from India's pharmaceutical industry

Antonecchia, Gianluca; Bhaskarabhatla, Ajay; Pennings, … - 2024

This paper develops a novel theory linking quantity discounts to bargaining power in scenarios where retailers, organized as a trade association, negotiate uniform wholesale prices with suppliers. Our theory predicts that suppliers offer greater quantity discounts in regional markets where they...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014583242

Tracking the fortunes of corporate psychedelia

Hager, Sandy Brian - 2024

In recent years, new biotech companies have emerged hoping to cash in on a medical psychedelics market expected to be worth billions. This article examines the business models of two of the largest such companies. According to conventional wisdom, for-profit players are best positioned to...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015070007

Show one more version 1

Tracking the fortunes of corporate psychedelia

Hager, Sandy Brian - 2024

Book / Working Paper

Long-term trends in racial and ethnic reporting and representation in US Alzheimer's clinical trials

Lin, Zhuoer; Sun, Ruochen; Rossi, Joseph S.; Lau, Kien; … - 2026

Alzheimer's disease (AD) disproportionately burdens racial and ethnic minority populations, yet the extent to which US clinical trials reflect this burden remains poorly understood. We conduct a systematic review of all 88 completed US-based Phase III AD drug trials between 1997 and 2023, using...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015626569

Show one more version 1

Long-term trends in racial and ethnic reporting and representation in US Alzheimer's clinical trials

Lin, Zhuoer; Sun, Ruochen; Ross, Joseph R.; Lau, Kien; … - 2026

Book / Working Paper

Access to medicines and intellectual property : taking advantage of trips flexibilities for post-covid-19 resilience in Africa

Eba Nguema, Ismaelline - 2026

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015632425

The long run economic effects of medical innovation and the role of opportunities

Bhalotra, Sonia; Clarke, Damian; Venkataramani, Atheendar S. - 2026

We leverage the introduction of the first antibiotic therapies in 1937 to examine the long run effects of early childhood pneumonia on adult educational attainment, employment, income, and work-related disability. Using census data, we document large average gains on all outcomes, alongside...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015656132

Show 4 more versions 4

The long run economic effects of medical innovation and the role of opportunities

Bhalotra, Sonia; Clarke, Damian; Venkataramani, Atheendar S. - 2026

Book / Working Paper

The long run economic effects of medical innovation and the role of opportunities

Bhalotra, Sonia; Clarke, Damian; Venkataramani, Atheendar S. - 2026

Book / Working Paper

The long run economic effects of medical innovation and the role of opportunities

Bhalotra, Sonia; Clarke, Damian; Venkataramani, Atheendar S. - 2026 - Revised April 2026

Edition: Revised April 2026

Book / Working Paper

The long run economic effects of medical innovation and the role of opportunities

Bhalotra, Sonia; Clarke, Damian; Venkataramani, Atheendar S. - 2025

Book / Working Paper

Preventing drug shortages through improved demand fulfillment : the untapped potential of postponement and flexibility

Blossey, Gregor; Hahn, Gerd J.; Koberstein, Achim - 2026

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015605913

Knowledge and vaccination in COVID-19 management efficiency : a Global Malmquist-Luenberger index analysis

Martínez Córdoba, Pedro José; Márquez Arenas, Lorena; … - 2026

The COVID-19 pandemic posed severe challenges for governments, presenting unknown situations and requiring decisions to be made under unprecedented uncertainty. Scientists responded fast, developing vaccines to mitigate the effects of the disease and improve pandemic management. This study...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015606817

A re-examination of issues related to the relief system for injury to health with vaccination and the report on suspected adverse reactions

Yasuoka, Masaya - 2026

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015608108

Who vaccinates when others matter? : social-circle mediated altruism in a heterogeneous vaccination game

Amann, Erwin; Alyousuf, Manar - 2026

We develop a population game with heterogeneous infection-loss types and social-circle mediated prosociality, where altruists internalize expected infection losses within a setting-specific circle. Equilibrium admits closed-form cutoff rules and an aggregate non-vaccination rate that reduces to...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015608488

Cognitive supply chain management and risk management in pharmaceuticals : the mediating roles of forecasting, synchronization, and transparency

Abushaikha, Ismail; AlQahtani, Munirah; Bwaliez, Omar M.; … - 2026

Background: This study examines the degree to which cognitive supply chain management (CSCM) indirectly enhances supply chain risk management (SCRM), addressing the lack of specific empirical research concerning the underlying mechanisms of this relationship. Specifically, this study tests the...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015611796

Timely access to new pharmaceuticals in Canada, the United States, and the European Union, 2026

Acri, Kristina M. L.; Assad, Lauren - 2026

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015613516

Artificial intelligence adoption for pharmaceutical salesforce performance : a case study in Kuwait

Abdallah, Wael; Aziza, Mulham; Chamas, Hassan Baz - 2026

Purpose - The research aims to investigate the factors influencing the adoption of artificial intelligence (AI) in pharmaceutical industry companies, specifically focusing on its impact on salesforce performance. Design/methodology/approach - We collected research data from pharmaceutical...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015592497

UN Human Rights Council resolutions on access to medicines and the use of TRIPS flexibilities : a review

Syam, Nirmalya - 2026

This paper reviews almost twenty years of the United Nations Human Rights Council’s (UNHRC) work on access to medicines. The UNHRC has repeatedly framed access to medicines as part of the right to health and has urged States to rely on flexibilities in the Agreement on Trade Related Aspects of...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015573247

Pharmaceutical advertising in dynamic equilibrium

Dubois, Pierre; Pakes, Ariel - 2026

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015637921

Show 2 more versions 2

Pharmaceutical advertising in dynamic equilibrium

Dubois, Pierre; Pakes, Ariel - 2026

Book / Working Paper

Pharmaceutical Advertising in Dynamic Equilibrium

Dubois, Pierre; Pakes, Ariel - 2026

Book / Working Paper

Biopharmaceutical innovation: corporate governance for equitable global health

Gehl Sampath, Padmashree; Tulum, Öner; Lazonick, William - 2026

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015639806

Cost pass-through, price competition, and market power in brick-and-mortar pharmacies : evidence from Germany

Gail, Maximilian M. - 2026

In the German pharmacy market, strictly regulated prescription (Rx) drug prices coexist with free pricing for over-the-counter (OTC) drugs. This paper investigates the extent of market power in the non-prescription segment (OTC drugs and non-pharmaceuticals) and explores the role of Rx drugs in...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015643184

An analysis of implementing pharmaceutical cost-containment measures in Egypt : lessons from international experiences

Nassar, Heba; Reda, Dalia - 2026

Purpose - The main goal of this paper is to analyze the implementation of pharmaceuticals cost-containment measures in Egypt. Design/methodology/approach - This paper adopts descriptive and analytical techniques to assess the extent of implementing pharmaceutical cost-containment measures in...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015560586

How does big data analytics drive supply chain resilience in pharmaceuticals? : exploring the roles of supply chain risk and ambidexterity

Al-Nuimat, Sara Sami; Al-Zu'bi, Zu'bi M. F.; Abdallah, … - 2026

Background: The primary objective of this study is to investigate the influence of big data analytics (BDA) on supply chain (SC) risk, SC ambidexterity, and SC resilience. It further examines the effects of SC risk and SC ambidexterity on SC resilience and explores their mediating roles in the...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015611770

Therapeutic substitutability under scrutiny : defining relevant markets in EU pharmaceutical law

Kaushik, Kanika - 2026

Market definition is fundamental to EU competition law. It serves as a preliminary step in assessing dominance, anti-competitive conduct, and merger control. With respect to the pharmaceutical sector, traditional approaches to defining the relevant market face specific hurdles. Therapeutic...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015638991

Decoding drug search under public funding : rates, directions, and social impacts in an agent-based model

Dosi, Giovanni; Palagi, Elisa; Roventini, Andrea; … - 2026

By extending the framework presented by Dosi et al. (2023b), we build an evolutionary agent-based model of the pharmaceutical sector featuring a government and a Public Research Lab investing in R&D and innovating across different therapeutic areas. After having empirically validated our...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015614624

Blockchain-enabled traceability in pharmaceutical supply chains : a mapping review of evidence for visibility, anti-counterfeiting, and chain-of-custody control

Diaz, Félix; Cerna, Nhell; Liza, Rafael; Motta, Bryan; … - 2026

Background: Blockchain is increasingly proposed to strengthen pharmaceutical traceability, anti-counterfeiting, and chain of custody in multi-actor supply chains, but the evidence base remains heterogeneous in technical rigor and operational clarity. Methods: We conducted a mapping review of...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015647687

Incentives, surrogates, and long-run vaccination

Campos-Mercade, Pol; Meier, Armando N.; Meier, Stephan; … - 2026

Can monetary incentives improve health behaviors in the long run, and do commonly used surrogate outcomes capture these effects? We study these questions in the context of vaccination using a large-scale field experiment. The experiment combines commonly used surrogates-vaccination intentions,...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015654644

Show one more version 1

Incentives, surrogates, and long-run vaccination

Campos Mercade, Pol; Meier, Armando N.; Meier, Stephan; … - 2026

Book / Working Paper

The post-fentanyl urbanization of the opioid epidemic

Kucera, Alexander; Scavette, Adam; Porreca, Zachary - 2026

The geography of the U.S. opioid epidemic has shifted repeatedly across epidemic waves. After a period in which overdose mortality increasingly burdened rural and suburban communities, the fentanyl era appears to have redirected the crisis toward dense urban cores. Here, we document a post-2015...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015637823

Pre-booked vaccination appointments as a nudge : evidence from a nationwide intervention

Moeller, Jakob; Halla, Martin; Thomas, Tobias - 2026

We study the effect of pre-booked COVID-19 vaccination appointments using a na- tionwide campaign in Austria. Leveraging administrative microdata on more than 450,000 initially unvaccinated adults, we exploit cross-state variation in program participation and staggered appointment timing in a...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015653640

Patents over patients? : exploring the variegated financialization of the pharmaceuticals industry through mergers and acquisitions

Keenan, Liam; Monteath, Timothy; Wójcik, Dariusz - 2023

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014312894

Market power and regulation in pharmaceutical markets

Gugler, Klaus; Szücs, Florian - 2023

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014321635

Decision criteria for partial nationalization of pharmaceutical supply chain : a scoping review

Marrone, Patrícia Véras; Mathias, Fabio Rampazzo; … - 2023

(1) Background: Any disturbance in the pharmaceutical supply chain (PSC) can disrupt the supply of medicines and affect the efficiency of health systems. Due to shortages in the global pharma supply chain over the past few years and the complex nature of free trade and its limitations when...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10013500649

Parallel imports under a manufacturer rebate and a price freeze : evidence from Germany

Birg, Laura - 2023

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014266802

Show one more version 1

Parallel imports under a manufacturer rebate and a price freeze: Evidence from Germany

Birg, Laura - 2022

Article

More cost-sharing, less cost? : evidence on reference price drugs

Herr, Annika; Stühmeier, Torben; Wenzel, Tobias - 2023

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014266816

The EU's open strategic autonomy in the field of pharmaceuticals: Overcoming import dependencies for antibiotics through the EU authority HERA

Bayerlein, Michael - 2023

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10013550119

Show one more version 1

The EU's open strategic autonomy in the field of pharmaceuticals : overcoming import dependencies for antibiotics through the EU authority HERA

Bayerlein, Michael - 2023

Book / Working Paper

Evaluating quality reward and other interventions to mitigate US drug shortages

Naumov, Sergey; Noh, In Joon; Zhao, Hui - 2025

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376804

Supply base attributes and diversion risk in a supply chain for hazardous pharmaceutical products

Skilton, Paul F.; Mackelprang, Alan; Sepehrirad, Ramin; … - 2025

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376815

Towards the integration of precision medicine in psychiatric care delivery : evaluating the impact of clinical guidelines on drug-related adverse events

Yang, Jingwen; Mishra, Anant; Sinha, Kingshuk K. - 2025

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376820

Matters arising : cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing-remitting multiple sclerosis : a systematic review

Lazzaro, Carlo; Bergamaschi, Roberto; Zaffaroni, Mauro; … - 2025

Background In their interesting systematic review, Gallehzan et al. quoted our article Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing-remitting multiple sclerosis (RRMS) in Italy. While we are grateful to Gallehzan et al. for their interest in the...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015371820

The EU community pharmacy market : the density and its influencing factors

Schwaabe, Selina - 2025

Community pharmacies deliver high-quality health care and are responsible for medication safety. The goal of the government is to ensure nationwide, accessible, and affordable medical health-care services provided by pharmacies. Therefore, the per capita density of community pharmacies matters....

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015211718

Combating vaccine hesitancy : the case of HPV vaccination

Díaz, Lina; Martínez, Déborah; Márquez, Karina; … - 2025

Cervical cancer, primarily caused by persistent Human Papillomavirus (HPV) infection, remains one of the leading causes of cancer-related deaths among women in developing countries. Although HPV vaccines are widely available in these regions, vaccine uptake remains persistently low. To address...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015271625

Why are opioid prescribing rates higher in rural versus urban areas?

Modestino, Alicia; Young, Gary J.; Hasan, Md Mahmudul; … - 2025

Patients in rural areas have higher rates of opioid use and overdose than those in urban areas that are linked to the greater prevalence and amounts of opioids prescribed. We merge individual claims data with county-level supply and demand factors to examine this relationship between...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015324281

Consideration of the relief system for injury to health with vaccination : a focused analysis of applications related to COVID-19 vaccinations

Yasuoka, Masaya - 2025

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015196370

Integrated shelf-life rules for multi-level pharmaceutical tablets manufacturing processes

Simonis, Michael; Nickel, Stefan - 2025

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015198531

Multi-criteria decision analysis for sustainable medicinal supply chain problems with adaptability and challenges issues

Momena, Alaa Fouad; Gazi, Kamal Hossain; Mondal, Sankar … - 2025

Background: The supply chain refers to the full process of creating and providing a good or service, starting with the raw materials and ending with the final customer. It requires cooperation and coordination between many parties, including the suppliers, manufacturers, distributors, retailers,...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015337493

What fueled the illicit opioid epidemic? : new evidence from a takeover of white powder heroin markets

Donahoe, J. Travis; Soliman, Adam - 2025

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015337607

Application of the Bolar exception : different approaches in the EU

Doubinsky, Dmytro - 2025

This Research Paper addresses the growing problem of access to essential medicines, focusing on the role of intellectual property rights, particularly patent rights, in restricting access by enabling pharmaceutical market monopolies that keep drug prices high. The paper explores the Bolar...

Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015182911